(Q43754696)

26 November 2017

title

Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis (English)

1 reference

26 November 2017

1 reference

2

1 reference

26 November 2017

4

Quyyumi AA

1 reference

26 November 2017

Prasad A

1

1 reference

26 November 2017

Waclawiw MA

series ordinal

3

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Journal of the American College of Cardiology

26 November 2017

published in

1 reference

26 November 2017

volume

38

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

1089-1095

1 reference

Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

The endothelium--modulator of vascular smooth-muscle tone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Endothelium-dependent hyperpolarization of canine coronary smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Control of coronary vascular tone by nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Angiotensin II receptors in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Inhibition of nitric oxide synthesis during the cold pressor test in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Evidence that macrophages in atherosclerotic lesions contain angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Effect of enalaprilat on nitric oxide activity in coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Impact of coronary risk factors on contribution of nitric oxide and adenosine to metabolic coronary vasodilation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Coronary microcirculation: autoregulation and metabolic control

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Coronary microcirculation in health and disease. Summary of an NHLBI workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

Angiotensin II increases monocyte binding to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

The renin-angiotensin system and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901511-X

7 January 2021

10.1016/S0735-1097(01)01511-X

Identifiers

DOI

1 reference

26 November 2017

1 reference